4//SEC Filing
Favet Michael 4
Accession 0001209191-21-028324
CIK 0001528287other
Filed
Apr 25, 8:00 PM ET
Accepted
Apr 26, 5:16 PM ET
Size
11.5 KB
Accession
0001209191-21-028324
Insider Transaction Report
Form 4
NeuroPace IncNPCE
Favet Michael
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2021-04-26$0.03/sh+15,385$462→ 22,947 total(indirect: See Footnote) - Conversion
Series A' Preferred Stock
2021-04-26−343→ 0 total(indirect: See Footnote)Exercise: $0.00→ Common Stock (343 underlying) - Conversion
Series B' Preferred Stock
2021-04-26−7,219→ 0 total(indirect: See Footnote)Exercise: $0.00→ Common Stock (7,219 underlying) - Conversion
Common Stock
2021-04-26+7,562→ 7,562 total(indirect: See Footnote)
Footnotes (2)
- [F1]Shares are held by the Favet Living Trust, of which the Reporting Person and the Reporting Person's spouse serve as co-trustees.
- [F2]Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock at any time upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date.
Documents
Issuer
NeuroPace Inc
CIK 0001528287
Entity typeother
Related Parties
1- filerCIK 0001855656
Filing Metadata
- Form type
- 4
- Filed
- Apr 25, 8:00 PM ET
- Accepted
- Apr 26, 5:16 PM ET
- Size
- 11.5 KB